OSR Holdings, Inc.

OSRHNASDAQHealthcare● Active

$0.40

+$0.02(+3.87%)

Market Cap$9900207

P/E Ratio—

52W High$1.79

52W Low$0.375

Avg Volume6.4M

Open$0.39

Beta0.61

Overview

OSR Holdings, Inc. (OSRH) Insider Trading

Form 4 buy vs sell counts, ratio, and sentiment — switch this quarter or last 12 months; chart and transactions below.

SEC EDGAR · FMP · OSRH · as of Jun 9, 2026

Activity summary

Buy transactions

P-Purchase only

Sell transactions

12 Months

Buy/Sell ratio

∞

Buy/Sell (by trades)

Overall sentiment

BULLISH

↑ Buy 100%Active transactions only · RSU vesting excluded0% Sell ↓

OSR Holdings, Inc. insiders have been net buyers of shares over the past 12 Months, which may signal confidence in the company's outlook.

▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · Buy = P-Purchase only · Sell = S-Sale only

As of Jun 9, 2026

OSRH insider buying and selling by quarter

OSRH insider selling · OSRH insider buying stocks · quarterly insider activity

Total insider buying (incl. awards)Total insider selling

2.4M1.2M0

2023 Q1

Mobile shows last 4Q · Desktop shows full 8Q

▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · last 8 quarters

As of Jun 9, 2026

Recent insider transactions

OSRH executive sell shares · OSRH board member insider trading · OSRH insider trading SEC filing

Showing 32 most recent · Common Stock · Form 4 only

Scroll horizontally to see all columns

Date	Insider	Type	Shares	Price	Value	After trans.	Filing
Feb 14, 2025	Bellevue Global Life Science Investors LLC 10 percent owner	Other	43,000	—	—	2,043,500	Form 4
Feb 14, 2025	Hwang Kuk Hyoun President and CEO · Director	Other	3,123,970	—	—	12,699,104	Form 4
Feb 14, 2025	Hwang Kuk Hyoun President and CEO · Director	Other	7,531,634	—	—	9,575,134	Form 4
Feb 14, 2025	Hwang Kuk Hyoun President and CEO · Director	Other	43,000	—	—	2,043,500	Form 4
Mar 23, 2023	Hwang Kuk Hyoun CEO · Director	Other	20,000	—	—	2,000,500	Form 4
Mar 23, 2023	Yoo David Jin CFO	Award	20,000	—	—	20,000	Form 4
Mar 23, 2023	Bellevue Global Life Science Investors LLC 10 percent owner	Other	20,000	—	—	2,000,500	Form 4
Feb 21, 2023	Hwang Kuk Hyoun CEO · Director	Other	225,000	—	—	2,025,000	Form 4
Feb 21, 2023	Hwang Kuk Hyoun CEO · Director	Other	4,500	—	—	2,020,500	Form 4
Feb 21, 2023	Bellevue Global Life Science Investors LLC 10 percent owner	Other	225,000	—	—	2,025,000	Form 4
Feb 21, 2023	Bellevue Global Life Science Investors LLC 10 percent owner	Other	4,500	—	—	2,020,500	Form 4
Feb 14, 2023	REED STEVEN Director	Award	20,000	—	—	20,000	Form 4
Feb 14, 2023	Chung In Chul Director	Award	20,000	—	—	20,000	Form 4
Feb 14, 2023	Roberts Rad Director	Award	20,000	—	—	20,000	Form 4
Feb 14, 2023	Park Jin Whan Director	Award	20,000	—	—	20,000	Form 4
Feb 14, 2023	Euh Hosun Director	Award	20,000	—	—	20,000	Form 4
Feb 14, 2023	Bellevue Global Life Science Investors LLC 10 percent owner	Award	430,000	$10.00	$4.30M⚡	1,800,000	Form 4
Feb 14, 2023	Bellevue Global Life Science Investors LLC 10 percent owner	Other	20,000	—	—	1,705,000	Form 4
Feb 14, 2023	Bellevue Global Life Science Investors LLC 10 percent owner	Other	20,000	—	—	1,685,000	Form 4
Feb 14, 2023	Bellevue Global Life Science Investors LLC 10 percent owner	Other	20,000	—	—	1,665,000	Form 4
Feb 14, 2023	Bellevue Global Life Science Investors LLC 10 percent owner	Other	20,000	—	—	1,645,000	Form 4
Feb 14, 2023	Bellevue Global Life Science Investors LLC 10 percent owner	Other	20,000	—	—	1,625,000	Form 4
Feb 14, 2023	Bellevue Global Life Science Investors LLC 10 percent owner	Other	225,000	—	—	1,400,000	Form 4
Feb 14, 2023	Bellevue Global Life Science Investors LLC 10 percent owner	Other	30,000	—	—	1,370,000	Form 4
Feb 14, 2023	Hwang Kuk Hyoun CEO · Director	Award	430,000	$10.00	$4.30M⚡	1,800,000	Form 4

Bellevue Global Life Science Investors LLC

10 percent owner

Other

Date

Feb 14

43,000

Price

—

Value

—

View Form 4 on SEC.gov

Hwang Kuk Hyoun

President and CEO · Director

Other

Date

Feb 14

3,123,970

Price

—

Value

—

View Form 4 on SEC.gov

Hwang Kuk Hyoun

President and CEO · Director

Other

Date

Feb 14

7,531,634

Price

—

Value

—

View Form 4 on SEC.gov

Hwang Kuk Hyoun

President and CEO · Director

Other

Date

Feb 14

43,000

Price

—

Value

—

View Form 4 on SEC.gov

Hwang Kuk Hyoun

CEO · Director

Other

Date

Mar 23

20,000

Price

—

Value

—

View Form 4 on SEC.gov

Yoo David Jin

CFO

Award

Date

Mar 23

20,000

Price

—

Value

—

View Form 4 on SEC.gov

Bellevue Global Life Science Investors LLC

10 percent owner

Other

Date

Mar 23

20,000

Price

—

Value

—

View Form 4 on SEC.gov

Hwang Kuk Hyoun

CEO · Director

Other

Date

Feb 21

225,000

Price

—

Value

—

View Form 4 on SEC.gov

Hwang Kuk Hyoun

CEO · Director

Other

Date

Feb 21

4,500

Price

—

Value

—

View Form 4 on SEC.gov

Bellevue Global Life Science Investors LLC

10 percent owner

Other

Date

Feb 21

225,000

Price

—

Value

—

View Form 4 on SEC.gov

Bellevue Global Life Science Investors LLC

10 percent owner

Other

Date

Feb 21

4,500

Price

—

Value

—

View Form 4 on SEC.gov

REED STEVEN

Director

Award

Date

Feb 14

20,000

Price

—

Value

—

View Form 4 on SEC.gov

Chung In Chul

Director

Award

Date

Feb 14

20,000

Price

—

Value

—

View Form 4 on SEC.gov

Roberts Rad

Director

Award

Date

Feb 14

20,000

Price

—

Value

—

View Form 4 on SEC.gov

Park Jin Whan

Director

Award

Date

Feb 14

20,000

Price

—

Value

—

View Form 4 on SEC.gov

Euh Hosun

Director

Award

Date

Feb 14

20,000

Price

—

Value

—

View Form 4 on SEC.gov

Bellevue Global Life Science Investors LLC

10 percent owner

Award

Date

Feb 14

430,000

Price

$10.00

Value

$4.30M ⚡

View Form 4 on SEC.gov

Bellevue Global Life Science Investors LLC

10 percent owner

Other

Date

Feb 14

20,000

Price

—

Value

—

View Form 4 on SEC.gov

Bellevue Global Life Science Investors LLC

10 percent owner

Other

Date

Feb 14

20,000

Price

—

Value

—

View Form 4 on SEC.gov

Bellevue Global Life Science Investors LLC

10 percent owner

Other

Date

Feb 14

20,000

Price

—

Value

—

View Form 4 on SEC.gov

Bellevue Global Life Science Investors LLC

10 percent owner

Other

Date

Feb 14

20,000

Price

—

Value

—

View Form 4 on SEC.gov

Bellevue Global Life Science Investors LLC

10 percent owner

Other

Date

Feb 14

20,000

Price

—

Value

—

View Form 4 on SEC.gov

Bellevue Global Life Science Investors LLC

10 percent owner

Other

Date

Feb 14

225,000

Price

—

Value

—

View Form 4 on SEC.gov

Bellevue Global Life Science Investors LLC

10 percent owner

Other

Date

Feb 14

30,000

Price

—

Value

—

View Form 4 on SEC.gov

Hwang Kuk Hyoun

CEO · Director

Award

Date

Feb 14

430,000

Price

$10.00

Value

$4.30M ⚡

View Form 4 on SEC.gov

⚡ = value ≥ $1M · Award/Option price shows — · formType=4 · securityName=Common Stock · url → sec.gov/Archives/edgar

1 / 2

▸ Source: SEC EDGAR · Form 4 filings · ⚡ = value ≥ $1M · Award/Option price shows —

About OSRH insider trading

OSRH insider trades

OSR Holdings, Inc. (OSRH) insider trading data is sourced from SEC Form 4 filings submitted by corporate insiders, including OSRH. Over the past 12 months, 0 insiders have filed transactions with the SEC. OSRH insiders have been primarily buying, which may reflect pre-scheduled Rule 10b5-1 plan executions.

For OSR Holdings, Inc.'s institutional ownership breakdown and insider ownership percentage, see the Ownership tab → Ownership tab →

Buy/Sell signal logic

acquisitionOrDisposition field:

A = Acquisition (buy) · D = Disposition (sell)

RSU vesting (M-Exempt) excluded from sentiment

Form 4SEC filing required within 2 business days of any insider transaction

10b5-1Pre-scheduled trading plan that allows insiders to sell on autopilot

Open MktDirect purchase or sale on the open market (excludes awards, options)

Ownership SEC filings Financial statements Price history Forecast & ratings Earnings

Frequently asked questions

OSRH insider trading · 5 questions

The insiders of OSR Holdings, Inc. (OSRH) include executives and directors such as OSRH, among others. Over the past 12 months, 0 insiders have filed Form 4 transactions with the SEC. Insider transactions are required to be reported within 2 business days of the trade date.

OSRH board member insider tradingwho are OSRH insidersOSRH insider rosterOSR Holdings, Inc. executives insider activity

▸ Source: FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · acquisitionOrDisposition A=Buy, D=Sell · RSU vesting (M-Exempt) excluded from sentiment bar · As of Jun 9, 2026